Vor Biopharma Inc. — Director's Dealing 2021

Feb 10, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Vor Biopharma Inc. (VOR)
CIK: 0001817229
Period of Report: 2021-02-09

Reporting Person: RA CAPITAL MANAGEMENT, L.P. (Director, 10% Owner)
Reporting Person: RA Capital Healthcare Fund LP (Director, 10% Owner)
Reporting Person: Kolchinsky Peter (Director, 10% Owner)
Reporting Person: Shah Rajeev M. (Director, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-02-09	Common Stock	C	1664549	—	Acquired	1664549	Indirect
2021-02-09	Common Stock	C	280330	—	Acquired	280330	Indirect
2021-02-09	Common Stock	C	3784120	—	Acquired	5448669	Indirect
2021-02-09	Common Stock	C	1414026	—	Acquired	1694356	Indirect
2021-02-09	Common Stock	P	2848596	$18	Acquired	8297265	Indirect
2021-02-09	Common Stock	P	130970	$18	Acquired	1825326	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-02-09	Series A-2 Preferred Stock	$	C	22637875	Disposed		Common Stock (1664549)	Indirect
2021-02-09	Series A-2 Preferred Stock	$	C	3812500	Disposed		Common Stock (280330)	Indirect
2021-02-09	Series B Preferred Stock	$	C	51464036	Disposed		Common Stock (3784120)	Indirect
2021-02-09	Series B Preferred Stock	$	C	19230770	Disposed		Common Stock (1414026)	Indirect

Footnotes

F1: Each share of Series A-2 Preferred Stock and Series B Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 13.6-for-one basis, and had no expiration date.

F2: These securities are held directly by RA Capital Healthcare Fund, L.P. (the "Fund").

F3: These securities are held directly by RA Capital Nexus Fund, L.P. (the " Nexus Fund").

F4: RA Capital Management, L.P. (the "Adviser") is the investment manager for the Fund and the Nexus Fund. The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. The Adviser, the Adviser GP, Dr. Kolchinsky and Mr. Shah disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein.